Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
[cited 2025 Nov 8]
The Evidence Gap: No Human Clinical Data Currently, there is no published human study demonstrating that sublingual semaglutide drops produce meaningful weight loss
The compound does not have a Drug Identification Number, Natural Product Number, or Homeopathic Drug Number, and Health Canada has named BPC-157 explicitly in seizure advisories targeting unauthorized injectable peptide vendors operating in Canada since 2023
and (c) FDA-approved products containing semaglutide and tirzepatide are available
Both reported gastrointestinal symptoms as the most common adverse events, mainly mild to moderate
If you need a course of antibiotics while on semaglutide, let your provider know so they can help manage any symptoms
